Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Predictions

buy
Vanda Pharmaceuticals

Start price
Target price
Perf. (%)
€3.86
14.04.24
-
14.04.25
36.01%
22:26

buy
Forum Energy Technologies Inc.

Start price
Target price
Perf. (%)
€18.30
13.04.24
-
13.04.25
-7.65%
31.07.24

buy
Harmony Gold Mining ADR

Start price
Target price
Perf. (%)
€8.70
13.04.24
-
13.04.25
2.30%
22:26

National Bank Holdings A

Start price
Target price
Perf. (%)
€30.60
13.04.24
-
13.04.25
26.33%
31.07.24

Vicor Corp.

Start price
Target price
Perf. (%)
€34.51
13.04.24
-
13.04.25
9.82%
22:26

Franklin Street Properties Corp.

Start price
Target price
Perf. (%)
€1.82
13.04.24
-
13.04.25
-37.40%
31.07.24

Getty Realty Corp.

Start price
Target price
Perf. (%)
€24.60
13.04.24
-
13.04.25
12.28%
31.07.24

buy
Leju Holdings Ltd. ADR

Start price
Target price
Perf. (%)
€0.97
13.04.24
-
13.04.25
-
11.04.24

buy
Tsakos Energy Navigation Ltd.

Start price
Target price
Perf. (%)
€23.96
13.04.24
-
13.04.25
2.50%
31.07.24

Ambarella Inc.

Start price
Target price
Perf. (%)
€43.51
13.04.24
-
13.04.25
1.82%
22:26

buy
MEI Pharma Inc.

Start price
Target price
Perf. (%)
€4.38
13.04.24
-
13.04.25
-
22.07.23

Quinstreet Inc.

Start price
Target price
Perf. (%)
€16.30
13.04.24
-
13.04.25
6.75%
31.07.24

buy
Vera Bradley Inc.

Start price
Target price
Perf. (%)
€5.95
13.04.24
-
13.04.25
1.68%
31.07.24

Liquidia Technologies Inc

Start price
Target price
Perf. (%)
€13.78
13.04.24
€12.00
13.04.25
-18.00%
27.04.24

Probably not worthwhile Investment
EBIT decline/stagnation expected
Low dividend yield expected
Revenue decline/stagnation expected
Adaptimmune Therapeutics PLC ADR

Start price
Target price
Perf. (%)
€1.07
13.04.24
€1.00
13.04.25
-2.80%
27.04.24

Probably not worthwhile Investment
Lower EBIT Margin than peer group
Bad rating
ROE lower than 10% per year
Enlivex Therapeutics Ltd.

Start price
Target price
Perf. (%)
€1.51
13.04.24
€2.00
13.04.25
-0.66%
27.04.24

negative Cash Flow expected
Few uniques
Growths slower than the competition
Below average Marketposition
Hovnanian Enter. A

Start price
Target price
Perf. (%)
€131.00
12.04.24
-
12.04.25
47.33%
31.07.24

Brinker International Inc.

Start price
Target price
Perf. (%)
€42.60
12.04.24
€36.64
12.04.25
39.67%
22:26

buy
Patrick Industries Inc.

Start price
Target price
Perf. (%)
€100.00
12.04.24
€122.12
12.04.25
19.50%
31.07.24

buy
Deutsche Rohstoff AG

Start price
Target price
Perf. (%)
€40.70
12.04.24
€42.00
12.04.25
6.14%
24.04.24

Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
Rising EBIT margin expected
Fair valuation
buy
Chuys Holdings Inc.

Start price
Target price
Perf. (%)
€25.80
12.04.24
€37.59
12.04.25
-
18.08.21

buy
Dynex Capital Inc.

Start price
Target price
Perf. (%)
€10.88
12.04.24
€13.63
12.04.25
6.51%
22:26

buy
G1 Therapeutics

Start price
Target price
Perf. (%)
€4.30
12.04.24
€11.28
12.04.25
-9.58%
22:26

buy
Papa John's International Inc.

Start price
Target price
Perf. (%)
€58.50
12.04.24
€70.48
12.04.25
-29.19%
22:26

buy
Cerus Corp.

Start price
Target price
Perf. (%)
€1.61
12.04.24
€4.70
12.04.25
29.45%
22:26